Topics

EMA Panel Backs First Treatment for Acute Hepatic Porphyria

10:07 EST 31 Jan 2020 | Medscape

The European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for the first treatment for acute hepatic porphyria.
International Approvals

Original Article: EMA Panel Backs First Treatment for Acute Hepatic Porphyria

NEXT ARTICLE

More From BioPortfolio on "EMA Panel Backs First Treatment for Acute Hepatic Porphyria"

Quick Search

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...